跳至主要内容
临床试验/NCT02246517
NCT02246517Unknown早期 1 期

The Effect of N2O on Chronic Neuropathic Pain

Tel-Aviv Sourasky Medical Center1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
入组人数
20
试验地点
1
主要终点
change in adult pain as measured by visual Analog Scale for Pain (VAS Pain)

研究概览

简要总结

Important pharmacological agents for treatment of chronic neuropathic pain such as ketamine block NMDA receptors. Nitrous oxide, an inhalant agent used extensively In anesthesia, also have antagonist property of NMDA receptors. The investigators hypothesize that prolonged treatment with N2O can alleviate chronic neuropathic pain of different causes (e.g. diabetic neuropathy, post herpetic neuralgia etc.).

详细描述

Important pharmacological agents for treatment of chronic neuropathic pain such as ketamine block NMDA receptors. Nitrous oxide, an inhalant agent used extensively In anesthesia, also have antagonist property of NMDA receptors. The investigators hypothesize that prolonged treatment with N2O can alleviate chronic neuropathic pain of different causes (e.g. diabetic neuropathy, post herpetic neuralgia etc.). In order to examine our theory we Will recruit 40 patients aged 18-65 that suffer from chronic neuropathic pain. The patients will be divided to two groups of which half will receive treatment with N2O and half with placebo (pure O2) as a repeated weekly treatment for 4 weeks. At the beginning of the each session the patient will be asked to fill questionnaires regarding their pain quality and severity

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • men and women at the age 18-65
  • patient that suffer from chronic neuropathic pain
  • DN4 score >4
  • takes pain medication on a regular basis
  • Didn't get epidural injection for the pas month
  • signed an informed consent form

排除标准

  • patients that suffer from chronic lung disease.
  • patients with cancer
  • patients with heart disease
  • pregnant and lactate woman
  • patients that suffer from depression

研究组 & 干预措施

Oxygen

Placebo Comparator

100% Oxygen by Aspiration for 5 min

干预措施: Oxygen (Drug)

N2O&Oxygen

Experimental

70% N2O & 30% Oxygen by Aspiration for 5 min

干预措施: N2O (Drug)

结局指标

主要结局

change in adult pain as measured by visual Analog Scale for Pain (VAS Pain)

时间窗: baseline and average of week for 4 weeks

Assessment of pain in the last 24 hours before the visit by VAS

次要结局

  • change in adult pain as measured by Short-Form McGill Pain Questionnaire (SF-MPQ)(baseline and average of week for 4 weeks)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

michal roll

Dr

Tel-Aviv Sourasky Medical Center

研究点 (1)

Loading locations...

相似试验

The Effect of N2O on Chronic Neuropathic Pain... | 临床试验